<?xml version="1.0" encoding="UTF-8"?>
<p id="Par35">Although clinical insights into complement activation following SARS-CoV-2 infection are limited
 <sup>
  <xref ref-type="bibr" rid="CR145">145</xref>
 </sup>, the above findings indicate that unrestrained complement activation — mainly at the downstream terminal phases of the complement cascades — may contribute to endothelial cell injury, thrombosis and intravascular coagulation, ultimately leading to multi-systemic organ failure in patients with COVID-19 (ref.
 <sup>
  <xref ref-type="bibr" rid="CR137">137</xref>
 </sup>).
</p>
